Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Recruiting now
Conditions studied: Central Nervous System Neoplasm, Leptomeningeal Neoplasm, Metastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm
In brief
This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.
Key facts
- Study ID
- NCT04988009
- Run by
- M.D. Anderson Cancer Center
- People needed
- 200
- Starts
- 2020-08-20
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-03-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
- Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
- An in-person visit
- A telemedicine appointment
You may not qualify if…
- Encounter occurred with the assistance of official language translation support
- Patients with telephone encounters (without interactive video)
- New patient or consult visits
- Neither patient nor caregiver present during the visit are available or able to answer survey questions
Where it is running
- M D Anderson Cancer Center — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.